RECENT NEWS
TheStreet.com  Jul 2 
Readers weigh in on Spectrum Pharma, Cell Therapeutics and Geron, and force us to explain -- again -- TheStreet's rules on stock ownership.
Reuters  Jul 2 
Some of Europe's cash-strapped biotech companies may just be able to see a light at the end of the tunnel.
UnBiasedTrading (TM)  Jul 2 
The equities markets remained above the channel support that I marked and showed here yesterday. I've summarized most of the pros and cons in my posts here over recent days. The Nasdaq appears stronger, even though today's slump in the biotech...
MarketWatch  Jul 1 
Drug stocks were mixed Wednesday, while shares of Myriad Genetics Inc. tanked on news that 2009 revenue would come in below its previously issued forecast.
Jutia Group  Jul 1 
There are a number of health care reform plans on the drawing boards right now, and they all seem to come with mind-numbing sticker shock. The administration’s new plan and Senator Kennedy’s plan are both estimated to cost $1 trillion...
FierceBiotech  Jul 1 
With a number of UK biotechs struggling to find cash to stay afloat, investors are raising some sharp questions about the pay packages that executives in the industry earn. A recent survey by Nature Biotechnology concluded that the average CEO in...
Wall Street Journal  Jun 30 
As U.K. biotechs face collapse, investors are asking why some senior executives and board members are getting big salaries and bonuses.
Investment U  Jun 30 
Health Care Reform: Five Ways to Profit With Biotech Stocks & Bond Funds by Marc Lichtenfeld, Advisory Panelist Wednesday, July 1, 2009: Issue #1031 There are a number of health care reform plans on the drawing boards right now, and they...
Small Cap Center  Jun 30 
Quebec-based biotechnology company Medicago (TSX: V.MDG) announced results Tuesday from an immunogenicity study in mice with its new vaccine candidate for the influenza A (H1N1) virus.
Investment U  Jun 30 
Becton Dickson and Company (NYSE: BDX): Stock of the Day by David Fessler, Advisory Panelist Analysts are starting to pile into the biotech bandwagon now. And for good reason: the AMEX Biotech Index is actually lower today than it was nine...
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
BULLS: REASONS TO BUY

 
100% agree
 
Big Mergers Could Mean Big Gains For Biotechnology

 
100% agree
 
Biotech Churns Out Big Returns in any market

 
100% agree
 
The One Market Soaring Now

BEARS: REASONS TO SELL
Bears: Reasons To Sell
Feeling Bearish? Be the first to explain why this would make a poor investment
See All (0)
 
TOP CONTRIBUTORS

Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genetech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors.




[edit] Industry Information

[edit] Major Biotechnology Companies

[edit] Biotechnology Industry Trends & Forces

[edit] High Pipeline Risk for New Drugs

[edit] Dependence on Health Insurance/Medicare Coverage

[edit] Dependence on Governmental Regulations

[edit] High Volatility and Instability at Start-up

[edit] Litigation Risk

[edit] Market Share

[edit] References

  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Companies in the Biotechnology Industry (208)

 
Worried about pump and dump?
We review changes
for stock spam
Want to make Wikinvest better?
We need your help,
contribute today
Do you write software?
We are recruiting
the best engineers
Like Wikinvest?
Spread the word —
Tell your friends!
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki